Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Qureator logo — Create to Cure

Qureator

Create to Cure

Founded 2020 United States San Diego, United States 22 employees Series A Total: $515.00M Biotechnology, Life Sciences

General Information

Company Name Qureator
Founded Year 2020
Location United States San Diego, United States
Founders / Decision Makers
Team member
Employees 22
Industries Biotechnology, Life Sciences
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Qureator . To contact Qureator , visit qureator.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Qureator compare?

A PDF of Qureator and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Qureator soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Qureator

Qureator is a biomedical company founded in 2017 and headquartered in San Diego, California. The company's Microphysiological Systems (MPS), known as Curiochips, aim to recapitulate the complexity of tissue microenvironments, providing microscale 3D cell culture conditions. Qureator's focus is on developing novel platforms and high-throughput disease models for precision medicine in areas of high unmet medical needs. The company's MPS enable investigators to perform co-cultures of multiple cell types in 3D and high-throughput screenings for biomedical research and drug discovery. Offering a variety of patient-derived in vitro models in organs-on-chips, Qureator's technology closely recapitulates the pathophysiology of diseases such as fibrosis, oncology, angiogenesis, ocular disease, and vasculogenesis. The company has garnered significant attention through collaborations with pharmaceutical companies and academic institutions for assay development, safety evaluation, and drug discovery. The conventional preclinical testing challenges have led to increased costs and time in drug discovery and development. In response, the company, along with the industry, has worked towards solving the mismatched preclinical testing for human drug treatments by developing several in vitro testing platforms. Qureator's Series A investment of $9.00M on March 17, 2022, signifies investor confidence in the potential of their Organ-on-a-Chip technology to mimic human model systems and evaluate drug candidates.

Business keywords: Microphysiological Systems, 3D cell culture, Disease models, Precision medicine, Biomedical research, Drug discovery, Organ-on-a-Chip, Assay development, Safety evaluation, Fibrosis, Oncology, Angiogenesis, Ocular disease, Vasculogenesis, Pharmaceutical collaborations

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $9.00M -
17 Mar 2022
Series A $6.00M 2
Winvest Venture Capital, HG Initiative
30 Dec 2020
Grant Undisclosed -
20 Oct 2019
Grant KRW500.00M 1
TIPS Program
20 Jul 2019

Qureator Alternatives & Competitors

View All Alternatives
Qureator vs
Emulate, Inc.
Emulate, Inc. United States

Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of human biol...

Series F
71 employees
Biotechnology, Health Care
Qureator vs
Lena Biosciences
Lena Biosciences United States

3D Cell Culture & Perfused-Organ-Panel MPS Technology

Grant
4 employees
Biotechnology, Life Sciences
Qureator vs
AlveoliX
AlveoliX Switzerland

In-vitro models inspired by nature Ι Organs-on-Chip

Grant
11 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Qureator

Create to Cure
Qureator was founded in 2020.
Qureator is headquartered in San Diego, United States.
Qureator operates in Biotechnology and Life Sciences. Its work centres on Microphysiological Systems, 3D cell culture, Disease models and Precision medicine.
Qureator has approximately 22 employees.
Qureator has completed 4 funding rounds, raising a total of $515.00M. The latest funding stage is Series A.
Top alternatives and competitors to Qureator include Emulate, Inc., Lena Biosciences, AlveoliX , React4life, InvivoSciences® Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Qureator and Emulate, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Qureator , https://bouncewatch.com/company/qureator, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes